<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01408719</url>
  </required_header>
  <id_info>
    <org_study_id>B2010:216</org_study_id>
    <nct_id>NCT01408719</nct_id>
  </id_info>
  <brief_title>Effect of Beta-Glucan on Cholesterol Lowering</brief_title>
  <official_title>Effect of Beta-Glucan Molecular Weight and Viscosity on the Mechanism of Cholesterol Lowering in Humans</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Manitoba</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Agriculture and Agri-Food Canada</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Manitoba</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary aim of this study is to determine whether the cholesterol-lowering efficacy of
      barley b- glucan varied as function of molecular weight (MW) and the total daily amount
      consumed. Our second aim is to investigate the mechanism responsible for the action,
      specifically, whether β-glucan lowers circulating cholesterol concentration via inhibiting
      cholesterol absorption and synthesis. Thirdly, we aim to determine if any gene-diet
      interactions are associated with cholesterol lowering by barley β-glucan. In addition, we aim
      to investigate the alteration of the gut microbiota after β-glucan consumption and the
      correlation between the altered gut microbiota and cardiovascular disease risk factors.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study consists of four dietary phases which are separated by &gt;28 days wash-out period.
      During the treatment phase, participants will be provided with all meals for the 35 day
      period. Breakfast meals will be consumed under the supervision of the research staff and
      lunch, dinner and snacks will be provided to take home in take-out packaging. While subjects
      are on the wash-out period they will return to their normal diet. The meals are on a 7 day
      rotating schedule that reflect an average Canadian diet. Changes in blood lipids, body
      weight, and waist circumference will be measured during each treatment phase. Cholesterol
      absorption and synthesis will be examined by stable isotope method. Single nucleotide
      polymorphisms (SNPs), rs3808607 of gene CYP7A1and rs429358 and rs7412 will be determined
      byTaqMan® SNP Genotyping assay following the manufacturer's protocol. Fecal samples will be
      collected at the end of each intervention phase and will be subjected to Illumina sequencing
      of 16S rRNA genes.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2010</start_date>
  <completion_date type="Actual">February 2012</completion_date>
  <primary_completion_date type="Actual">February 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changs in Total Cholesterol</measure>
    <time_frame>Beginning and end of each phase</time_frame>
    <description>Fasted total cholesterol concentration will be measured using the automated enzymatic methods.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes in LDL Cholesterol</measure>
    <time_frame>Beginning and end of each phase</time_frame>
    <description>Serum LDL cholesterol will be estimated using the Friedewald equation.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cholesterol Absorption/Synthesis</measure>
    <time_frame>End of each phase</time_frame>
    <description>The rate of cholesterol absorption and synthesis will be measured in each intervention phase using single stable isotope labelling technique.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Potential Gene-nutrient Interactions: CYP7A1 and APOE</measure>
    <time_frame>Once for each participant</time_frame>
    <description>The Single Nucleotide Polymorphism (SNP) rs3808607 of CYP7A1 gene, rs429358 and rs7412 of APOE gene, and their associations with different blood lipid responses to beta-glucan interventions will be determined.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in Body Weight and Waist Circumference(WC)</measure>
    <time_frame>Every day for body weight; beginning and end of each phase for WC</time_frame>
    <description>Body weight will be monitored every day when subject visits the Richardson Centre. Waist circumference will be measured at the beginning and end of each study phase.</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">45</enrollment>
  <condition>Hypercholesterolemia</condition>
  <arm_group>
    <arm_group_label>5g LMW beta glucan</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>5 gram low molecular weight barley beta-glucan diet for 35 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3g HMW beta glucan</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>3 gram high molecular weight barley beta-glucan diet for 35 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3g LMW beta glucan</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>3 grams of low molecular weight beta-glucan diet for 35 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>control diet containing negligible amount of beta glucan</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Control</intervention_name>
    <description>Minimal beta-glucan</description>
    <arm_group_label>5g LMW beta glucan</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>3g LMW beta-glucan</intervention_name>
    <description>3grams beta-glucan</description>
    <arm_group_label>3g HMW beta glucan</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>5g LMW beta-glucan</intervention_name>
    <description>5 grams beta-glucan</description>
    <arm_group_label>3g LMW beta glucan</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>3g HMW beta-glucan</intervention_name>
    <description>3 grams of high molecular weight beta-glucan</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  BMI 20-40 kg/m2

          -  Fasting cholesterol levels of 5.0-8.0 mmol/L

          -  Fasting serum LDL cholesterol levels of 2.7-5.0 mmol/L

        Exclusion Criteria:

          -  Pregnant or lactating

          -  Taking lipid lowering medication or nutritional supplements that affect blood lipids

          -  Dietary restrictions which would affect consuming the study diet for 5-wk for four
             study phases.

          -  Not deemed healthy by study physician
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>78 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nancy Ames, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>AAFC</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Richardson Centre for Functional Foods and Neutraceuticals</name>
      <address>
        <city>Winnipeg</city>
        <state>Manitoba</state>
        <zip>R3T 2N2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>October 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 2, 2011</study_first_submitted>
  <study_first_submitted_qc>August 2, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 3, 2011</study_first_posted>
  <results_first_submitted>August 12, 2013</results_first_submitted>
  <results_first_submitted_qc>January 24, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">March 11, 2014</results_first_posted>
  <last_update_submitted>October 7, 2015</last_update_submitted>
  <last_update_submitted_qc>October 7, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 5, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Manitoba</investigator_affiliation>
    <investigator_full_name>Dr. Nancy Ames</investigator_full_name>
    <investigator_title>Research Scientist &amp; Adjunct Professor</investigator_title>
  </responsible_party>
  <keyword>Beta-Glucan</keyword>
  <keyword>Barley</keyword>
  <keyword>Molecular Weight</keyword>
  <keyword>Viscosity</keyword>
  <keyword>Cholesterol</keyword>
  <keyword>Stable isotope</keyword>
  <keyword>Gene-nutrient interaction</keyword>
  <keyword>Gut microbiota</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypercholesterolemia</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Participants were recruited at the Richardson Centre for Functionals Foods and Nutraceuticals, University of Manitoba, Winnipeg during July 2010 to May 2011</recruitment_details>
      <pre_assignment_details>Over 200 subjects were screened; 45 subjects were enrolled in the study and randomly assigned to the experimental diets (treatment groups).</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Sequence 1</title>
          <description>3g LMW followed by control, followed by 3g HMW, followed by 5g LMW</description>
        </group>
        <group group_id="P2">
          <title>Sequence 2</title>
          <description>Control, followed by 3g HMW, followed by 5g LMW, followed by 3g LMW</description>
        </group>
        <group group_id="P3">
          <title>Sequence 3</title>
          <description>3g LMW, followed by 3g HMW, followed by 5g LMW, followed by control</description>
        </group>
        <group group_id="P4">
          <title>Sequence 4</title>
          <description>5g LMW, followed by 3g LMW, followed by 3g HMW, followed by control</description>
        </group>
        <group group_id="P5">
          <title>Sequence 5</title>
          <description>3g HMW, followed by 3g LMW, followed by control, followed by 5g LMW</description>
        </group>
        <group group_id="P6">
          <title>Sequence 6</title>
          <description>control, followed by 5g LMW, followed by 3g HMW, followed by 3g LMW</description>
        </group>
        <group group_id="P7">
          <title>Sequence 7</title>
          <description>5g LMW, followed by 3g LMW, followed control, followed by 3g HMW</description>
        </group>
        <group group_id="P8">
          <title>Sequence 8</title>
          <description>3g LMW, followed by 3g HMW, followed by control, followed by 5g HMW</description>
        </group>
        <group group_id="P9">
          <title>Sequence 9</title>
          <description>Control, followed by 5g HMW, followed by 3g LMW, followed by 3g HMW</description>
        </group>
        <group group_id="P10">
          <title>Sequence 10</title>
          <description>Control, followed by 3g LMW, followed by 5g LMW, followed by 3g HMW</description>
        </group>
        <group group_id="P11">
          <title>Sequence 11</title>
          <description>3g HMW, followed by control, followed by 5g LMW, followed by 3g LMW</description>
        </group>
        <group group_id="P12">
          <title>Sequence 12</title>
          <description>5g LMW, followed by control, followed by 3g LMW, followed by 3g HMW</description>
        </group>
        <group group_id="P13">
          <title>Sequence 13</title>
          <description>3g HMW, followed by control, followed by 3g LMW, followed by 5g LMW</description>
        </group>
        <group group_id="P14">
          <title>Sequence 14</title>
          <description>3g LMW, followed by 5g LMW, followed by 3g HMW, followed by control</description>
        </group>
        <group group_id="P15">
          <title>Sequence 15</title>
          <description>3g LMW, followed by 5g LMW, followed by control, followed by 3g HMW</description>
        </group>
        <group group_id="P16">
          <title>Sequence 16</title>
          <description>3g HMW, followed by 5g LMW, followed 3g LMW, followed by control</description>
        </group>
        <group group_id="P17">
          <title>Sequence 17</title>
          <description>3g HMW, followed by 3g LMW, followed 5g LMW, followed by control</description>
        </group>
        <group group_id="P18">
          <title>Sequence 18</title>
          <description>5g LMW, followed by 3g HMW, followed by control, followed by 3g LMW</description>
        </group>
        <group group_id="P19">
          <title>Sequence 19</title>
          <description>Control, followed by 3g HMW, followed by 3g LMW, followed by 5g LMW</description>
        </group>
        <group group_id="P20">
          <title>Sequence 20</title>
          <description>3g HMW, followed by 5g LMW, followed by control, followed by 3g LMW</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>First Intervention (35 Days)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="2"/>
                <participants group_id="P4" count="2"/>
                <participants group_id="P5" count="4"/>
                <participants group_id="P6" count="3"/>
                <participants group_id="P7" count="2"/>
                <participants group_id="P8" count="3"/>
                <participants group_id="P9" count="2"/>
                <participants group_id="P10" count="1"/>
                <participants group_id="P11" count="2"/>
                <participants group_id="P12" count="2"/>
                <participants group_id="P13" count="2"/>
                <participants group_id="P14" count="5"/>
                <participants group_id="P15" count="1"/>
                <participants group_id="P16" count="2"/>
                <participants group_id="P17" count="3"/>
                <participants group_id="P18" count="2"/>
                <participants group_id="P19" count="1"/>
                <participants group_id="P20" count="1"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="2"/>
                <participants group_id="P5" count="3"/>
                <participants group_id="P6" count="3"/>
                <participants group_id="P7" count="2"/>
                <participants group_id="P8" count="3"/>
                <participants group_id="P9" count="1"/>
                <participants group_id="P10" count="1"/>
                <participants group_id="P11" count="2"/>
                <participants group_id="P12" count="2"/>
                <participants group_id="P13" count="2"/>
                <participants group_id="P14" count="4"/>
                <participants group_id="P15" count="1"/>
                <participants group_id="P16" count="2"/>
                <participants group_id="P17" count="2"/>
                <participants group_id="P18" count="2"/>
                <participants group_id="P19" count="0"/>
                <participants group_id="P20" count="1"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="1"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="1"/>
                <participants group_id="P10" count="0"/>
                <participants group_id="P11" count="0"/>
                <participants group_id="P12" count="0"/>
                <participants group_id="P13" count="0"/>
                <participants group_id="P14" count="1"/>
                <participants group_id="P15" count="0"/>
                <participants group_id="P16" count="0"/>
                <participants group_id="P17" count="1"/>
                <participants group_id="P18" count="0"/>
                <participants group_id="P19" count="1"/>
                <participants group_id="P20" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Washout Period (28 Days)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="2"/>
                <participants group_id="P5" count="3"/>
                <participants group_id="P6" count="3"/>
                <participants group_id="P7" count="2"/>
                <participants group_id="P8" count="3"/>
                <participants group_id="P9" count="1"/>
                <participants group_id="P10" count="1"/>
                <participants group_id="P11" count="2"/>
                <participants group_id="P12" count="2"/>
                <participants group_id="P13" count="2"/>
                <participants group_id="P14" count="4"/>
                <participants group_id="P15" count="1"/>
                <participants group_id="P16" count="2"/>
                <participants group_id="P17" count="2"/>
                <participants group_id="P18" count="2"/>
                <participants group_id="P19" count="0"/>
                <participants group_id="P20" count="1"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="2"/>
                <participants group_id="P5" count="3"/>
                <participants group_id="P6" count="3"/>
                <participants group_id="P7" count="2"/>
                <participants group_id="P8" count="3"/>
                <participants group_id="P9" count="1"/>
                <participants group_id="P10" count="1"/>
                <participants group_id="P11" count="2"/>
                <participants group_id="P12" count="2"/>
                <participants group_id="P13" count="2"/>
                <participants group_id="P14" count="4"/>
                <participants group_id="P15" count="1"/>
                <participants group_id="P16" count="2"/>
                <participants group_id="P17" count="2"/>
                <participants group_id="P18" count="2"/>
                <participants group_id="P19" count="0"/>
                <participants group_id="P20" count="1"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
                <participants group_id="P11" count="0"/>
                <participants group_id="P12" count="0"/>
                <participants group_id="P13" count="0"/>
                <participants group_id="P14" count="0"/>
                <participants group_id="P15" count="0"/>
                <participants group_id="P16" count="0"/>
                <participants group_id="P17" count="0"/>
                <participants group_id="P18" count="0"/>
                <participants group_id="P19" count="0"/>
                <participants group_id="P20" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Second Intervention (35 Days)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="2"/>
                <participants group_id="P5" count="3"/>
                <participants group_id="P6" count="3"/>
                <participants group_id="P7" count="2"/>
                <participants group_id="P8" count="3"/>
                <participants group_id="P9" count="1"/>
                <participants group_id="P10" count="1"/>
                <participants group_id="P11" count="2"/>
                <participants group_id="P12" count="2"/>
                <participants group_id="P13" count="2"/>
                <participants group_id="P14" count="4"/>
                <participants group_id="P15" count="1"/>
                <participants group_id="P16" count="2"/>
                <participants group_id="P17" count="2"/>
                <participants group_id="P18" count="2"/>
                <participants group_id="P19" count="0"/>
                <participants group_id="P20" count="1"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="2"/>
                <participants group_id="P5" count="3"/>
                <participants group_id="P6" count="3"/>
                <participants group_id="P7" count="2"/>
                <participants group_id="P8" count="3"/>
                <participants group_id="P9" count="1"/>
                <participants group_id="P10" count="1"/>
                <participants group_id="P11" count="2"/>
                <participants group_id="P12" count="2"/>
                <participants group_id="P13" count="2"/>
                <participants group_id="P14" count="3"/>
                <participants group_id="P15" count="1"/>
                <participants group_id="P16" count="2"/>
                <participants group_id="P17" count="2"/>
                <participants group_id="P18" count="2"/>
                <participants group_id="P19" count="0"/>
                <participants group_id="P20" count="1"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
                <participants group_id="P11" count="0"/>
                <participants group_id="P12" count="0"/>
                <participants group_id="P13" count="0"/>
                <participants group_id="P14" count="1"/>
                <participants group_id="P15" count="0"/>
                <participants group_id="P16" count="0"/>
                <participants group_id="P17" count="0"/>
                <participants group_id="P18" count="0"/>
                <participants group_id="P19" count="0"/>
                <participants group_id="P20" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Washout Period (28 Days)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="2"/>
                <participants group_id="P5" count="3"/>
                <participants group_id="P6" count="3"/>
                <participants group_id="P7" count="2"/>
                <participants group_id="P8" count="3"/>
                <participants group_id="P9" count="1"/>
                <participants group_id="P10" count="1"/>
                <participants group_id="P11" count="2"/>
                <participants group_id="P12" count="2"/>
                <participants group_id="P13" count="2"/>
                <participants group_id="P14" count="3"/>
                <participants group_id="P15" count="1"/>
                <participants group_id="P16" count="1"/>
                <participants group_id="P17" count="2"/>
                <participants group_id="P18" count="2"/>
                <participants group_id="P19" count="0"/>
                <participants group_id="P20" count="1"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="2"/>
                <participants group_id="P5" count="3"/>
                <participants group_id="P6" count="3"/>
                <participants group_id="P7" count="2"/>
                <participants group_id="P8" count="3"/>
                <participants group_id="P9" count="1"/>
                <participants group_id="P10" count="1"/>
                <participants group_id="P11" count="2"/>
                <participants group_id="P12" count="2"/>
                <participants group_id="P13" count="2"/>
                <participants group_id="P14" count="3"/>
                <participants group_id="P15" count="1"/>
                <participants group_id="P16" count="1"/>
                <participants group_id="P17" count="2"/>
                <participants group_id="P18" count="2"/>
                <participants group_id="P19" count="0"/>
                <participants group_id="P20" count="1"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
                <participants group_id="P11" count="0"/>
                <participants group_id="P12" count="0"/>
                <participants group_id="P13" count="0"/>
                <participants group_id="P14" count="0"/>
                <participants group_id="P15" count="0"/>
                <participants group_id="P16" count="0"/>
                <participants group_id="P17" count="0"/>
                <participants group_id="P18" count="0"/>
                <participants group_id="P19" count="0"/>
                <participants group_id="P20" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Third Intervention (35 Days)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="2"/>
                <participants group_id="P5" count="3"/>
                <participants group_id="P6" count="3"/>
                <participants group_id="P7" count="2"/>
                <participants group_id="P8" count="3"/>
                <participants group_id="P9" count="1"/>
                <participants group_id="P10" count="1"/>
                <participants group_id="P11" count="2"/>
                <participants group_id="P12" count="2"/>
                <participants group_id="P13" count="2"/>
                <participants group_id="P14" count="3"/>
                <participants group_id="P15" count="1"/>
                <participants group_id="P16" count="1"/>
                <participants group_id="P17" count="2"/>
                <participants group_id="P18" count="2"/>
                <participants group_id="P19" count="0"/>
                <participants group_id="P20" count="1"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="2"/>
                <participants group_id="P5" count="3"/>
                <participants group_id="P6" count="3"/>
                <participants group_id="P7" count="2"/>
                <participants group_id="P8" count="2"/>
                <participants group_id="P9" count="1"/>
                <participants group_id="P10" count="1"/>
                <participants group_id="P11" count="2"/>
                <participants group_id="P12" count="2"/>
                <participants group_id="P13" count="2"/>
                <participants group_id="P14" count="3"/>
                <participants group_id="P15" count="1"/>
                <participants group_id="P16" count="1"/>
                <participants group_id="P17" count="2"/>
                <participants group_id="P18" count="2"/>
                <participants group_id="P19" count="0"/>
                <participants group_id="P20" count="1"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="1"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
                <participants group_id="P11" count="0"/>
                <participants group_id="P12" count="0"/>
                <participants group_id="P13" count="0"/>
                <participants group_id="P14" count="0"/>
                <participants group_id="P15" count="0"/>
                <participants group_id="P16" count="0"/>
                <participants group_id="P17" count="0"/>
                <participants group_id="P18" count="0"/>
                <participants group_id="P19" count="0"/>
                <participants group_id="P20" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Washout Period (28 Days)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="2"/>
                <participants group_id="P5" count="3"/>
                <participants group_id="P6" count="3"/>
                <participants group_id="P7" count="2"/>
                <participants group_id="P8" count="2"/>
                <participants group_id="P9" count="1"/>
                <participants group_id="P10" count="1"/>
                <participants group_id="P11" count="2"/>
                <participants group_id="P12" count="2"/>
                <participants group_id="P13" count="1"/>
                <participants group_id="P14" count="3"/>
                <participants group_id="P15" count="1"/>
                <participants group_id="P16" count="1"/>
                <participants group_id="P17" count="2"/>
                <participants group_id="P18" count="2"/>
                <participants group_id="P19" count="0"/>
                <participants group_id="P20" count="1"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="2"/>
                <participants group_id="P5" count="3"/>
                <participants group_id="P6" count="3"/>
                <participants group_id="P7" count="2"/>
                <participants group_id="P8" count="2"/>
                <participants group_id="P9" count="1"/>
                <participants group_id="P10" count="1"/>
                <participants group_id="P11" count="2"/>
                <participants group_id="P12" count="2"/>
                <participants group_id="P13" count="1"/>
                <participants group_id="P14" count="3"/>
                <participants group_id="P15" count="1"/>
                <participants group_id="P16" count="1"/>
                <participants group_id="P17" count="2"/>
                <participants group_id="P18" count="2"/>
                <participants group_id="P19" count="0"/>
                <participants group_id="P20" count="1"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
                <participants group_id="P11" count="0"/>
                <participants group_id="P12" count="0"/>
                <participants group_id="P13" count="0"/>
                <participants group_id="P14" count="0"/>
                <participants group_id="P15" count="0"/>
                <participants group_id="P16" count="0"/>
                <participants group_id="P17" count="0"/>
                <participants group_id="P18" count="0"/>
                <participants group_id="P19" count="0"/>
                <participants group_id="P20" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Fourth Intervention (35 Days)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="2"/>
                <participants group_id="P5" count="3"/>
                <participants group_id="P6" count="3"/>
                <participants group_id="P7" count="2"/>
                <participants group_id="P8" count="2"/>
                <participants group_id="P9" count="1"/>
                <participants group_id="P10" count="1"/>
                <participants group_id="P11" count="2"/>
                <participants group_id="P12" count="2"/>
                <participants group_id="P13" count="1"/>
                <participants group_id="P14" count="3"/>
                <participants group_id="P15" count="1"/>
                <participants group_id="P16" count="1"/>
                <participants group_id="P17" count="2"/>
                <participants group_id="P18" count="2"/>
                <participants group_id="P19" count="0"/>
                <participants group_id="P20" count="1"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="2"/>
                <participants group_id="P5" count="3"/>
                <participants group_id="P6" count="3"/>
                <participants group_id="P7" count="2"/>
                <participants group_id="P8" count="2"/>
                <participants group_id="P9" count="1"/>
                <participants group_id="P10" count="1"/>
                <participants group_id="P11" count="2"/>
                <participants group_id="P12" count="2"/>
                <participants group_id="P13" count="1"/>
                <participants group_id="P14" count="3"/>
                <participants group_id="P15" count="1"/>
                <participants group_id="P16" count="1"/>
                <participants group_id="P17" count="2"/>
                <participants group_id="P18" count="2"/>
                <participants group_id="P19" count="0"/>
                <participants group_id="P20" count="1"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
                <participants group_id="P11" count="0"/>
                <participants group_id="P12" count="0"/>
                <participants group_id="P13" count="0"/>
                <participants group_id="P14" count="0"/>
                <participants group_id="P15" count="0"/>
                <participants group_id="P16" count="0"/>
                <participants group_id="P17" count="0"/>
                <participants group_id="P18" count="0"/>
                <participants group_id="P19" count="0"/>
                <participants group_id="P20" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>It is a cross over trial so the total number of participants is same throughout the study.</population>
      <group_list>
        <group group_id="B1">
          <title>Sequence 1</title>
          <description>3g LMW followed by control, followed by 3g HMW, followed by 5g LMW</description>
        </group>
        <group group_id="B2">
          <title>Sequence 2</title>
          <description>Control, followed by 3g HMW, followed by 5g LMW, followed by 3g LMW</description>
        </group>
        <group group_id="B3">
          <title>Sequence 3</title>
          <description>3g LMW, followed by 3g HMW, followed by 5g LMW, followed by control</description>
        </group>
        <group group_id="B4">
          <title>Sequence 4</title>
          <description>5g LMW, followed by 3g LMW, followed by 3g HMW, followed by control</description>
        </group>
        <group group_id="B5">
          <title>Sequence 5</title>
          <description>3g HMW, followed by 3g LMW, followed by control, followed by 5g LMW</description>
        </group>
        <group group_id="B6">
          <title>Sequence 6</title>
          <description>control, followed by 5g LMW, followed by 3g HMW, followed by 3g LMW</description>
        </group>
        <group group_id="B7">
          <title>Sequence 7</title>
          <description>5g LMW, followed by 3g LMW, followed control, followed by 3g HMW</description>
        </group>
        <group group_id="B8">
          <title>Sequence 8</title>
          <description>3g LMW, followed by 3g HMW, followed by control, followed by 5g HMW</description>
        </group>
        <group group_id="B9">
          <title>Sequence 9</title>
          <description>Control, followed by 5g HMW, followed by 3g LMW, followed by 3g HMW</description>
        </group>
        <group group_id="B10">
          <title>Sequence 10</title>
          <description>Control, followed by 3g LMW, followed by 5g LMW, followed by 3g HMW</description>
        </group>
        <group group_id="B11">
          <title>Sequence 11</title>
          <description>3g HMW, followed by control, followed by 5g LMW, followed by 3g LMW</description>
        </group>
        <group group_id="B12">
          <title>Sequence 12</title>
          <description>5g LMW, followed by control, followed by 3g LMW, followed by 3g HMW</description>
        </group>
        <group group_id="B13">
          <title>Sequence 13</title>
          <description>3g HMW, followed by control, followed by 3g LMW, followed by 5g LMW</description>
        </group>
        <group group_id="B14">
          <title>Sequence 14</title>
          <description>3g LMW, followed by 5g LMW, followed by 3g HMW, followed by control</description>
        </group>
        <group group_id="B15">
          <title>Sequence 15</title>
          <description>3g LMW, followed by 5g LMW, followed by control, followed by 3g HMW</description>
        </group>
        <group group_id="B16">
          <title>Sequence 16</title>
          <description>3g HMW, followed by 5g LMW, followed 3g LMW, followed by control</description>
        </group>
        <group group_id="B17">
          <title>Sequence 17</title>
          <description>3g HMW, followed by 3g LMW, followed 5g LMW, followed by control</description>
        </group>
        <group group_id="B18">
          <title>Sequence 18</title>
          <description>5g LMW, followed by 3g HMW, followed by control, followed by 3g LMW</description>
        </group>
        <group group_id="B19">
          <title>Sequence 19</title>
          <description>Control, followed by 3g HMW, followed by 3g LMW, followed by 5g LMW</description>
        </group>
        <group group_id="B20">
          <title>Sequence 20</title>
          <description>3g HMW, followed by 5g LMW, followed by control, followed by 3g LMW</description>
        </group>
        <group group_id="B21">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="2"/>
            <count group_id="B2" value="3"/>
            <count group_id="B3" value="1"/>
            <count group_id="B4" value="2"/>
            <count group_id="B5" value="3"/>
            <count group_id="B6" value="3"/>
            <count group_id="B7" value="2"/>
            <count group_id="B8" value="2"/>
            <count group_id="B9" value="1"/>
            <count group_id="B10" value="1"/>
            <count group_id="B11" value="2"/>
            <count group_id="B12" value="2"/>
            <count group_id="B13" value="1"/>
            <count group_id="B14" value="3"/>
            <count group_id="B15" value="1"/>
            <count group_id="B16" value="1"/>
            <count group_id="B17" value="2"/>
            <count group_id="B18" value="1"/>
            <count group_id="B19" value="1"/>
            <count group_id="B20" value="1"/>
            <count group_id="B21" value="35"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="46" spread="15.6"/>
                    <measurement group_id="B2" value="52.7" spread="3.5"/>
                    <measurement group_id="B3" value="40" spread="0"/>
                    <measurement group_id="B4" value="63" spread="1.4"/>
                    <measurement group_id="B5" value="70" spread="10.6"/>
                    <measurement group_id="B6" value="55" spread="14"/>
                    <measurement group_id="B7" value="55.5" spread="2.12"/>
                    <measurement group_id="B8" value="67" spread="1.4"/>
                    <measurement group_id="B9" value="57" spread="0"/>
                    <measurement group_id="B10" value="27" spread="0"/>
                    <measurement group_id="B11" value="62.5" spread="0.7"/>
                    <measurement group_id="B12" value="59.5" spread="4.9"/>
                    <measurement group_id="B13" value="62" spread="0"/>
                    <measurement group_id="B14" value="59.3" spread="3.8"/>
                    <measurement group_id="B15" value="76" spread="0"/>
                    <measurement group_id="B16" value="58" spread="0"/>
                    <measurement group_id="B17" value="53" spread="8.5"/>
                    <measurement group_id="B18" value="59" spread="0"/>
                    <measurement group_id="B19" value="65" spread="0"/>
                    <measurement group_id="B20" value="59" spread="0"/>
                    <measurement group_id="B21" value="57.9" spread="10.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="2"/>
                    <measurement group_id="B5" value="1"/>
                    <measurement group_id="B6" value="2"/>
                    <measurement group_id="B7" value="2"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="1"/>
                    <measurement group_id="B10" value="0"/>
                    <measurement group_id="B11" value="2"/>
                    <measurement group_id="B12" value="1"/>
                    <measurement group_id="B13" value="0"/>
                    <measurement group_id="B14" value="3"/>
                    <measurement group_id="B15" value="1"/>
                    <measurement group_id="B16" value="0"/>
                    <measurement group_id="B17" value="0"/>
                    <measurement group_id="B18" value="1"/>
                    <measurement group_id="B19" value="0"/>
                    <measurement group_id="B20" value="0"/>
                    <measurement group_id="B21" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="2"/>
                    <measurement group_id="B6" value="1"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="2"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="1"/>
                    <measurement group_id="B11" value="0"/>
                    <measurement group_id="B12" value="1"/>
                    <measurement group_id="B13" value="1"/>
                    <measurement group_id="B14" value="0"/>
                    <measurement group_id="B15" value="0"/>
                    <measurement group_id="B16" value="1"/>
                    <measurement group_id="B17" value="2"/>
                    <measurement group_id="B18" value="0"/>
                    <measurement group_id="B19" value="1"/>
                    <measurement group_id="B20" value="1"/>
                    <measurement group_id="B21" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Changs in Total Cholesterol</title>
        <description>Fasted total cholesterol concentration will be measured using the automated enzymatic methods.</description>
        <time_frame>Beginning and end of each phase</time_frame>
        <group_list>
          <group group_id="O1">
            <title>5g LMW Beta Glucan</title>
            <description>5 gram low molecular weight barley beta-glucan diet for 35 days
Control: Minimal beta-glucan</description>
          </group>
          <group group_id="O2">
            <title>3g HMW Beta Glucan</title>
            <description>3 gram high molecular weight barley beta-glucan diet for 35 days
3g LMW beta-glucan: 3grams beta-glucan</description>
          </group>
          <group group_id="O3">
            <title>3g LMW Beta Glucan</title>
            <description>3 grams of low molecular weight beta-glucan diet for 35 days
5g LMW beta-glucan: 5 grams beta-glucan</description>
          </group>
          <group group_id="O4">
            <title>Control</title>
            <description>control diet containing negligible amount of beta glucan
3g HMW beta-glucan: 3 grams of high molecular weight beta-glucan</description>
          </group>
        </group_list>
        <measure>
          <title>Changs in Total Cholesterol</title>
          <description>Fasted total cholesterol concentration will be measured using the automated enzymatic methods.</description>
          <units>mmol/L</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="30"/>
                <count group_id="O3" value="30"/>
                <count group_id="O4" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.42" spread="0.09"/>
                    <measurement group_id="O2" value="-0.60" spread="0.09"/>
                    <measurement group_id="O3" value="-0.46" spread="0.09"/>
                    <measurement group_id="O4" value="-0.30" spread="0.09"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Cholesterol Absorption/Synthesis</title>
        <description>The rate of cholesterol absorption and synthesis will be measured in each intervention phase using single stable isotope labelling technique.</description>
        <time_frame>End of each phase</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Potential Gene-nutrient Interactions: CYP7A1 and APOE</title>
        <description>The Single Nucleotide Polymorphism (SNP) rs3808607 of CYP7A1 gene, rs429358 and rs7412 of APOE gene, and their associations with different blood lipid responses to beta-glucan interventions will be determined.</description>
        <time_frame>Once for each participant</time_frame>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Changes in LDL Cholesterol</title>
        <description>Serum LDL cholesterol will be estimated using the Friedewald equation.</description>
        <time_frame>Beginning and end of each phase</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Changes in Body Weight and Waist Circumference(WC)</title>
        <description>Body weight will be monitored every day when subject visits the Richardson Centre. Waist circumference will be measured at the beginning and end of each study phase.</description>
        <time_frame>Every day for body weight; beginning and end of each phase for WC</time_frame>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Control</title>
          <description>Minimal barley and minimal beta-glucan</description>
        </group>
        <group group_id="E2">
          <title>3g HMW Beta-glucan</title>
          <description>3 grams high molecular weight barley beta-glucan</description>
        </group>
        <group group_id="E3">
          <title>3g LMW Beta-glucan</title>
          <description>3 grams low molecular weight barley beta-glucan</description>
        </group>
        <group group_id="E4">
          <title>5g LMW Beta-glucan</title>
          <description>5 grams low molecular weight barley beta-glucan</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="35"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="35"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Nancy Ames</name_or_title>
      <organization>Agriculture and Agri-food Canada</organization>
      <phone>204-474-7187</phone>
      <email>nancy.ames@agr.gc.ca</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

